Mar. 13 at 1:11 PM
$BRTX AI DD/ my DD T00 :"In context by Mid -2026, 🔑 intersection of Regenerative Medicine (stem cells) & Metabolic Health (obesity/diabetes) "HOTTEST" sectors in biotech.✅️ ✅️ Big Pharma is currently Desperate for "GLP-1 companions"—Technologies of ONLY
$BRTX !🔑Required to help patients lose fat Not lose muscle. Which is exactly where
$BRTX 's ThermoStem ((Brown Adipose Tissue is used to burn body fat )) platform patents are Required by Big Pharma to stop clients losing 20%+ of muscle mass in body fat loosing programs."✅️✅️
"When
$BRTX-100 (the Phase 2 asset) shows successful data and the 3 ThermoStem patents continue to be granted globally, valuation of a licensing deal changes 200%+ higher than the
$35 to
$75 million dollars..✅️ 🌞 Upfront Cash
$35 –
$75 million dollars Paid Immediately 🌞 upon signing of licensing by Big Pharma..** Be (( Higher than
$75 million when patent moat (US, Japan, Australia) is deemed "ironclad." )) as patents are very HOTTEST sector & is Big Pharma Required. "** ✅️ ((
$BRTX Market Cap of Only
$5.6 million is irrationally insane.)) Post 2-25 price $.223
Since Post
$BRTX
+38.83%
